News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
245,794 Results
Type
Article (24534)
Company Profile (44)
Press Release (221216)
Section
Business (70293)
Career Advice (1373)
Deals (13136)
Drug Delivery (81)
Drug Development (36182)
Employer Resources (165)
FDA (6433)
Job Trends (6665)
News (126852)
Policy (11467)
Tag
Academia (1480)
Alliances (19090)
Alzheimer's disease (622)
Antibody-drug conjugate (ADC) (54)
Approvals (6402)
Artificial intelligence (88)
Bankruptcy (116)
Best Places to Work (4625)
Breast cancer (61)
Cancer (512)
Cardiovascular disease (53)
Career advice (1156)
Cell therapy (117)
Clinical research (29373)
Collaboration (167)
COVID-19 (1512)
Data (556)
Diabetes (88)
Diagnostics (2321)
Drug pricing (59)
Earnings (19445)
Employer resources (141)
Events (29158)
Executive appointments (151)
FDA (6630)
Funding (167)
Gene therapy (105)
GLP-1 (450)
Government (1865)
Healthcare (7655)
Infectious disease (1559)
Inflammatory bowel disease (64)
Interviews (225)
IPO (4632)
Job creations (2151)
Job search strategy (1012)
Layoffs (246)
Legal (2360)
Lung cancer (93)
Management (52)
Manufacturing (113)
Medical device (4701)
Medtech (4704)
Mergers & acquisitions (8536)
Metabolic disorders (274)
Neuroscience (788)
NextGen Class of 2024 (3133)
Non-profit (2147)
Northern California (493)
Obesity (153)
Opinion (148)
Parkinson's disease (46)
People (24137)
Phase I (7153)
Phase II (12677)
Phase III (12014)
Pipeline (200)
Podcasts (86)
Policy (61)
Postmarket research (1317)
Preclinical (2736)
Radiopharmaceuticals (108)
Rare diseases (122)
Real estate (3394)
Recruiting (60)
Regulatory (7822)
Research institute (1274)
Resumes & cover letters (213)
Southern California (413)
Startups (1921)
The Weekly (53)
United States (4542)
Vaccines (385)
Weight loss (145)
Date
Today (37)
Last 7 days (293)
Last 30 days (1352)
Last 365 days (13411)
2024 (12278)
2023 (14539)
2022 (20820)
2021 (22676)
2020 (21126)
2019 (19515)
2018 (14735)
2017 (13861)
2016 (13404)
2015 (15468)
2014 (10466)
2013 (7678)
2012 (8168)
2011 (8766)
2010 (7321)
Location
Africa (501)
Asia (15941)
Australia (2987)
California (1066)
Canada (366)
China (124)
Colorado (49)
Connecticut (49)
Europe (43904)
Florida (152)
Georgia (63)
Illinois (145)
Indiana (73)
Maryland (208)
Massachusetts (796)
Michigan (69)
Minnesota (94)
New Jersey (376)
New York (385)
North Carolina (223)
Northern California (493)
Pennsylvania (266)
South America (652)
Southern California (413)
Texas (130)
Washington State (140)
245,794 Results for "zambon group spa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Amneal Enters into Exclusive European Licensing Agreement with Zambon Biotech for IPX203
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”) today announced that it has entered into an exclusive licensing agreement with Zambon Biotech SA, part of the Zambon group (“Zambon”), for IPX203 in the European Union, United Kingdom, and Switzerland.
February 27, 2024
·
9 min read
Press Releases
Zambon Taps Kinaxis to Enhance Transparency Across Global Supply Chain
September 23, 2024
·
3 min read
Business
Stevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco Moro
Stevanato Group S.p.A. announced today that its Board of Directors has appointed Franco Stevanato, a current director and the Executive Chairman of the Company, as its new Chief Executive Officer.
May 28, 2024
·
4 min read
Stevanato Group to Present at the Bank of America Securities Healthcare Conference
Stevanato Group S.p.A. announced that it will participate in the Bank of America Securities Healthcare Conference taking place from Tuesday, May 14, 2024 to Thursday, May 16, 2024.
May 1, 2024
·
1 min read
Business
Stevanato Group appoints Ugo Gay as Chief Operations Officer
Stevanato Group S.p.A. today announced the appointment of Ugo Gay as its new Chief Operations Officer (COO).
April 4, 2024
·
4 min read
Stevanato Group to Present at Upcoming Investor Conferences - May 23, 2024
Stevanato Group S.p.A. announced today that it will participate in two upcoming investor conferences. The Company will present at the William Blair Growth Stock Conference in Chicago on Tuesday, June 4, 2024 at 4:00 p.m. (CT), and at the Jefferies Healthcare Conference in New York
May 23, 2024
·
1 min read
Drug Development
Zambon Announces Publication of Phase 3 PROMIS I and II Study Results in The Lancet Respiratory Medicine Showing Efficacy Results of CMS I-neb in Patients with Non-Cystic Fibrosis Bronchiectasis Colonized with P. aeruginosa
September 12, 2024
·
9 min read
Business
Stevanato Group Reports Financial Results for the First Quarter of 2024
Stevanato Group S.p.A., a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced its financial results for the first quarter of 2024.
May 9, 2024
·
18 min read
Press Releases
Zambon Announces Publication of Phase 3 PROMIS I and II Study Results in The Lancet Respiratory Medicine Showing Efficacy Results of CMS I-neb in Patients with Non-Cystic Fibrosis Bronchiectasis Colonized with P. aeruginosa
September 13, 2024
·
8 min read
Deals
Donaldson Enters into Agreement to Acquire Minority Stake in Medica, S.p.A.
Donaldson Company, Inc., a leading worldwide provider of innovative filtration products and solutions, announced it has entered into a definitive agreement allowing the Company to purchase a 49% stake in Medica S.p.A.
April 29, 2024
·
5 min read
1 of 24,580
Next
